Glatiramer Acetate Injection, Solution
Product Images NDC 0378-6961
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 0378-6961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Time To Second Exacerbation (5cd25695 8a5c 48b6 Bd73 86a48de41493 02)
Figure 2: Median Cumulative Number Of Gd-enhancing Lesions (5cd25695 8a5c 48b6 Bd73 86a48de41493 03)
Instructions For Use Figure A (Image 14)
Instructions For Use Figure B (Image 15)
Instructions For Use Figure C (Image 16)
Instructions For Use Figure D (Image 17)
Instructions For Use Figure E (Image 18)
Instructions For Use Figure F (Image 19)
Instructions For Use Figure G (Image 20)
Instructions For Use Figure H (Image 21)
Instructions For Use Figure I (Image 22)
Instructions For Use Figure J (Image 23)
Instructions For Use Figure K (Image 24)
Instructions For Use Figure L (Image 25)
Glatiramer Acetate Injection 40 mg/ml Carton Label (Image 01)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.